Human medicines European public assessment report (EPAR): Omidria, phenylephrine,ketorolac, Lens Implantation, Intraocular;Pain, Postoperative, Date of authorisation: 28/07/2015, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Breast Neoplasms, Date of authorisation: 18/01/2021, Revision: 13, Status: Authorised

List of medicines under additional monitoring

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Skin Aging, Date of authorisation: 27/09/2019, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Meningitis, Meningococcal, Date of authorisation: 24/05/2017, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Riximyo, rituximab, Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Microscopic Polyangiitis;Wegener Granulomatosis, Date of authorisation: 15/06/2017, Revision: 14, Status: Authorised

Etoposide : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001333/202302

Etoposide : List of nationally authorised medicinal products - PSUSA/00001333/202302